McPhadden Samac Tuovi LLP has commenced a class action against Sony Corporation and other Sony companies related to the theft from Sony of personal information of Playstation network and Qriocity service users.  The theft may also include user credit card information.

The action has been brought on behalf of all persons in Canada who used Sony’s online PlayStation network or Qriocity services up to May 2, 2011 and who provided Sony with personal and/or credit or debit card information.

For further information, to register with our firm, and to receive future information about this case (click here) 

For our media release (click here) 

Update (click here).

An agreement (the terms of which are set out in detail in the "Settlement Agreement") has been reached between the Petitioner (the individual who brought the Class Action) and BCS in the Class Action. The Superior Court of Quebec approved the Settlement Agreement on September 8, 2010.

For further information please read the:

Notice of Settlement of  Bishop's College School Class Action Concerning Sexual and any Physical, Mental or Psychological Abuse.

McPhadden Samac Tuovi - BCS Class Action Page with downloadable copies of applicable forms

McPhadden Samac Tuovi have commenced a proposed class action against Johnson & Johnson and related companies relative to the collagen dermal filler Evolence. The Evolence claim involves people who were injected with Evolence and allegedly developed side effects that in some cases included disfiguring nodule formation.

Media Release.

For further information and instructions.

On behalf of two Mississauga, Ontario plaintiffs, McPhadden Samac Tuovi has commenced a proposed class action against GLAXOSMITHKLINE INC. and related companies ("GSK") relative to the drug Rosiglitazone which is widely used to lower blood sugar levels in people who suffer from Type II diabetes mellitus.  Rosiglitazone is marketed and sold by DSK under the brand names Avandia™, Avandamet™, and Avandaryl™. 

For further information and instructions.